Serum Creatinine Patterns in Neonates Treated with Therapeutic Hypothermia for Neonatal Encephalopathy.

Acute kidney injury Creatinine Newborn Perinatal asphyxia Precision medicine Reference values Therapeutic hypothermia

Journal

Neonatology
ISSN: 1661-7819
Titre abrégé: Neonatology
Pays: Switzerland
ID NLM: 101286577

Informations de publication

Date de publication:
2022
Historique:
received: 01 03 2022
accepted: 14 06 2022
pubmed: 8 7 2022
medline: 15 12 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

There is large variability in kidney function and injury in neonates with neonatal encephalopathy (NE) treated with therapeutic hypothermia (TH). Acute kidney injury (AKI) definitions that apply categorical approaches may lose valuable information about kidney function in individual patients. Centile serum creatinine (SCr) over postnatal age (PNA) may provide more valuable information in TH neonates. Data from seven TH neonates and one non-TH-treated, non-NE control cohorts were pooled in a retrospective study. SCr centiles over PNA, and AKI incidence (definition: SCr ↑≥0.3 mg/dL within 48 h, or ↑ ≥1.5 fold vs. the lowest prior SCr within 7 days) and mortality were calculated. Repeated measurement linear models were applied to SCr trends, modeling SCr on PNA, birth weight or gestational age (GA), using heterogeneous autoregressive residual covariance structure and maximum likelihood methods. Findings were compared to patterns in the control cohort. Among 1,136 TH neonates, representing 4,724 SCr observations, SCr (10th-25th-50th-75th-90th-95th) PNA centiles (day 1-10) were generated. In TH neonates, the AKI incidence was 132/1,136 (11.6%), mortality 193/1,136 (17%). AKI neonates had a higher mortality (37.2-14.3%, p < 0.001). Median SCr patterns over PNA were significantly higher in nonsurvivors (p < 0.01) or AKI neonates (p < 0.001). In TH-treated neonates, PNA and GA or birth weight explained SCr variability. Patterns over PNA were significantly higher in TH neonates to controls (801 neonates, 2,779 SCr). SCr patterns in TH-treated NE neonates are specific. Knowing PNA-related patterns enable clinicians to better assess kidney function and tailor pharmacotherapy, fluids, or kidney supportive therapies.

Identifiants

pubmed: 35797956
pii: 000525574
doi: 10.1159/000525574
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

686-694

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 The Author(s). Published by S. Karger AG, Basel.

Auteurs

Elif Keles (E)

Department of Neonatology, Gazi University, Faculty of Medicine, Ankara, Turkey.

Pia Wintermark (P)

Division of Newborn Medicine, Department of Pediatrics, McGill University, Montreal Children's Hospital, Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.

Floris Groenendaal (F)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, and Utrecht University, Utrecht, The Netherlands.
Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Noor Borloo (N)

Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.

Anne Smits (A)

Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

Annouschka Laenen (A)

Leuven Biostatistics and Statistical Bioinformatics Center (L-BioStat), KU Leuven, Leuven, Belgium.

Djalila Mekahli (D)

Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Department of Pediatric Nephrology, University Hospitals of Leuven, Leuven, Belgium.

Pieter Annaert (P)

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Suzan Şahin (S)

Department of Neonatology, Izmir Demokrasi University, Faculty of Medicine, Izmir, Turkey.

Mehmet Yekta Öncel (MY)

Department of Neonatology, İzmir Katip Çelebi University, Faculty of Medicine, İzmir, Turkey.

Valerie Chock (V)

Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Didem Armangil (D)

Neonatal Intensive Care Unit, Koru Hospital, Ankara, Turkey.

Esin Koc (E)

Department of Neonatology, Gazi University, Faculty of Medicine, Ankara, Turkey.

Malcolm R Battin (MR)

Newborn Service, Auckland District Health Board, Auckland, New Zealand.

Adam Frymoyer (A)

Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Karel Allegaert (K)

Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Department of Clinical Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH